AU2062601A - Peptides that stabilize protein antigens and enhance presentation to CD8+ T cells - Google Patents

Peptides that stabilize protein antigens and enhance presentation to CD8+ T cells

Info

Publication number
AU2062601A
AU2062601A AU20626/01A AU2062601A AU2062601A AU 2062601 A AU2062601 A AU 2062601A AU 20626/01 A AU20626/01 A AU 20626/01A AU 2062601 A AU2062601 A AU 2062601A AU 2062601 A AU2062601 A AU 2062601A
Authority
AU
Australia
Prior art keywords
peptides
cells
protein antigens
stabilize protein
enhance presentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20626/01A
Inventor
Elizabeth Chao
Janet Fields
Roger J. Kurlander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU2062601A publication Critical patent/AU2062601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU20626/01A 1999-12-06 2000-12-06 Peptides that stabilize protein antigens and enhance presentation to CD8+ T cells Abandoned AU2062601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16922799P 1999-12-06 1999-12-06
US60169227 1999-12-06
PCT/US2000/033027 WO2001040275A2 (en) 1999-12-06 2000-12-06 Peptides that stabilize protein antigens and enhance presentation to cd8+ t cells

Publications (1)

Publication Number Publication Date
AU2062601A true AU2062601A (en) 2001-06-12

Family

ID=22614723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20626/01A Abandoned AU2062601A (en) 1999-12-06 2000-12-06 Peptides that stabilize protein antigens and enhance presentation to CD8+ T cells

Country Status (2)

Country Link
AU (1) AU2062601A (en)
WO (1) WO2001040275A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201609083D0 (en) 2016-05-24 2016-07-06 Syntab Therapeutics Gmbh Synthetic compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212083A (en) * 1991-07-26 1993-05-18 Board Of Regents, The University Of Texas System Sequence for stabilizing proteins in bacteria
US5540926A (en) * 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
EP1025242A1 (en) * 1997-10-30 2000-08-09 Cornell Research Foundation, Inc. A method of inhibiting an immune response to a recombinant vector

Also Published As

Publication number Publication date
WO2001040275A3 (en) 2002-03-21
WO2001040275A2 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
AU2087401A (en) Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
AU6140998A (en) Peptides and peptide-loaded antigen presenting cells for the activation of ctl
AU2903999A (en) Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
AU7158398A (en) Use of lentiviral vectors for antigen presentation in dendritic cells
AU1363801A (en) Virtual presentation system and method
AU1951201A (en) Peptide antigens
AU1088399A (en) F-box proteins and genes
AU2273701A (en) Hla class i a2 tumor associated antigen peptides and vaccine compositions
AU2003276937A1 (en) Vegetable protein preparations and use thereof
AU7180198A (en) Human breast tumor-specific proteins
HK1141540A1 (en) Hsp peptides and analogs for modulation of immune responses via antigen presenting cells hsp
AU2086501A (en) Inducing cellular immune responses to carcinoembryonic antigen using peptide andnucleic acid compositions
AU1940301A (en) Tick antigens and compositions and methods comprising them
AU4642600A (en) Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells
AU2977500A (en) Advanced antigen presentation platform
AU6930200A (en) Use of lentiviral vectors for antigen presentation in dendritic cells
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2003204353A1 (en) Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU7308200A (en) Novel hev antigenic peptide and methods
AU2062601A (en) Peptides that stabilize protein antigens and enhance presentation to CD8+ T cells
AU8168898A (en) Interferon stimulating protein and uses thereof
AU2088701A (en) Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
AU2818695A (en) Natural killer cell enhancing factor c
AU6301698A (en) Anti-hiv peptides and proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase